Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

34.93
+0.06000.17%
Pre-market: 35.500.5700+1.63%04:07 EDT
Volume:1.96M
Turnover:68.26M
Market Cap:4.12B
PE:12.63
High:35.30
Open:34.87
Low:34.33
Close:34.87
52wk High:42.81
52wk Low:22.22
Shares:118.00M
Float Shares:116.45M
Volume Ratio:1.05
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):1.64
ROE:12.20%
ROA:26.40%
PB:-19.82
PE(LYR):21.30

Loading ...

Indivior CSO Christian Heidbreder Disposes of $764,432.04 in Common Shares

Reuters
·
Jul 14

Indivior Pharmaceuticals (INDV) Pushes Cost Cuts And Growth, Is It Still 17% Undervalued?

Simply Wall St.
·
Jun 26

Indivior Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Jun 18

Indivior Pharmaceuticals, Inc :  Barclays Initiates Coverage With Overweight Rating and Target Price $46

THOMSON REUTERS
·
Jun 18

Barclays Initiates Indivior at Overweight With $46 Price Target

MT Newswires Live
·
Jun 18

Indivior initiated with an Overweight at Barclays

TIPRANKS
·
Jun 18

U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis

Reuters
·
Jun 18

REFILE-FACTBOX-UK Market Exodus: Companies that moved away from London listing in recent years

Reuters
·
Jun 16

Indivior Chief Scientific Officer Christian Heidbreder disposes of 18,586 shares for $707,779.16

Reuters
·
Jun 13

UK Market Exodus: Companies that moved away from London listing in recent years

Reuters
·
Jun 12

Indivior CFO Ryan Preblick sells 36,000 shares for $1.36 million

Reuters
·
Jun 10

Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)

TIPRANKS
·
Jun 05

Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals' (INDV) Long-Acting OUD Treatment Narrative

Simply Wall St.
·
May 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

Indivior study links monthly injectable buprenorphine adherence to lower opioid relapse risk

Reuters
·
May 20

Indivior’s Earnings Call Highlights SUBLOCADE-Driven Surge

TIPRANKS
·
May 20

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership

TIPRANKS
·
May 16

Indivior eliminates chief scientific officer role; Heidbreder departs end-2026

Reuters
·
May 16

Indivior Pharmaceuticals Inc - to Eliminate Chief Scientific Officer Position Effective June 1, 2026 - SEC Filing

THOMSON REUTERS
·
May 16